Enabling future drug discovery by de novo design
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Computer‐assisted drug design is evolving as a source of innovation for drug discovery. In particular, de novo design approaches are being increasingly applied to find novel drug‐like compounds, molecular scaffolds, and bioisosteric replacements for established or unwanted fragments. Although some of the early software tools had a certain tendency to generate compounds of limited chemical attraction, modern de novo design algorithms put a strong emphasis on the synthesizability and drug‐likeness of machine‐generated compounds. We give an overview of the various methodologies for virtual compound construction, evaluation, and optimization in machina, and how they can support medicinal chemistry projects in the early phase of drug discovery. © 2011 John Wiley & Sons, Ltd. WIREs Comput Mol Sci 2011 1 742–759 DOI: 10.1002/wcms.49 This article is categorized under: Computer and Information Science > Chemoinformatics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728
SAR Index: Quantifying the Nature of Structure−Activity Relationships
Peltason, L., & Bajorath, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705713 · Cited by 201
Knowledge-Based Approach to de Novo Design Using Reaction Vectors
Patel, H., Bodkin, M. J., Chen, B., & Gillet, V. J. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800413m · Cited by 82 · cited 2×
“The software tools SYNOPSIS, 58 DOGS, 80 and the reaction vector method described by Patel et al. 105 belong to this category.”
BackgroundMethod
Cited by
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Self-citationGuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Neural‐Symbolic Machine Learning for Retrosynthesis and Reaction Prediction
Segler, M. H. S., & Waller, M. P. (2017) · Chemistry – A European Journal · doi:10.1002/chem.201605499 · Cited by 548
Synthetic Data for Deep Learning
Nikolenko, S. I. (2021) · Springer Optimization and Its Applications · doi:10.1007/978-3-030-75178-4 · Cited by 423
Molecular generative model based on conditional variational autoencoder for de novo molecular design
Lim, J., Ryu, S., Kim, J. W., & Kim, W. Y. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0286-7 · Cited by 421
Artificial Intelligence in Drug Design
Hessler, G., & Baringhaus, K.-H. (2018) · Molecules · doi:10.3390/molecules23102520 · Cited by 373
An Evolutionary Algorithm for de Novo Optimization of Functional Transition Metal Compounds
Chu, Y., Heyndrickx, W., Occhipinti, G., Jensen, V. R., & Alsberg, B. K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300865u · Cited by 90
Metadata
- Authors
- Hartenfeller, M., & Schneider, G.
- Venue
- WIREs Computational Molecular Science
- Publisher
- Wiley
- Published
- 2011-04-25
- Volume
- 1
- Issue
- 5
- Pages
- 742-759
- ISSN
- 1759-0876 (ISSN-L)
- 1759-0884
- OpenAlex
- W2009605433
- Cited by
- 83
- References
- 3
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.